Immunological suppression of head and neck carcinoma by dendritic cell tumor fusion vaccine

The successful treatment of cancer with dendritic cell (DC) tumor vaccine is highly dependent on the efficacy of antigen presentation and T cell activation. In the present study, a novel vaccine of DCs fused with autologous tumor cells was introduced, which had a marked ability to suppress head and...

Descripción completa

Detalles Bibliográficos
Autores principales: MOU, YONGBIN, XIE, HAO, HUANG, XIAOFENG, HAN, WEI, NI, YANHONG, SU, HANG, WANG, ZHIYONG, HU, QINGANG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833945/
https://www.ncbi.nlm.nih.gov/pubmed/24260079
http://dx.doi.org/10.3892/ol.2013.1633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833945/
https://www.ncbi.nlm.nih.gov/pubmed/24260079
http://dx.doi.org/10.3892/ol.2013.1633

Ejemplares similares